mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
NSC632839 |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.005 |
mRNA |
BRD-A86708339 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.006 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.006 |
mRNA |
masitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.007 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.008 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.008 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.008 |
mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.008 |
mRNA |
BRD-K90370028 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.008 |